These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11270767)

  • 1. Reducing premature death and renal failure in Australian aboriginals: a community-based cardiovascular and renal protective program.
    McLaren B
    Med J Aust; 2001 Feb; 174(4):201-2. PubMed ID: 11270767
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program.
    Hoy WE; Baker PR; Kelly AM; Wang Z
    Med J Aust; 2000 May; 172(10):473-8. PubMed ID: 10901769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not just a renal epidemic among Australian Aboriginals.
    Flicker L; Lucas RE; Ewald D
    Med J Aust; 1999 Feb; 170(4):191-2. PubMed ID: 10078194
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term trends in Indigenous deaths from chronic diseases in the Northern Territory: a foot on the brake, a foot on the accelerator.
    Thomas DP; Condon JR; Anderson IP; Li SQ; Halpin S; Cunningham J; Guthridge SL
    Med J Aust; 2006 Aug; 185(3):145-9. PubMed ID: 16893354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community.
    Hoy WE; Wang Z; Baker PR; Kelly AM
    Kidney Int Suppl; 2003 Feb; (83):S66-73. PubMed ID: 12864878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease in aboriginals in New South Wales: a very different picture to the Northern Territory.
    Cass A; Gillin AG; Horvath JS
    Med J Aust; 1999 Oct; 171(8):407-10. PubMed ID: 10590742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal disease in Australian Aborigines.
    Hoy W
    Nephrol Dial Transplant; 2000 Sep; 15(9):1293-7. PubMed ID: 10978381
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention of renal and cardiovascular disease: results of a renal and cardiovascular treatment program in an Australian aboriginal community.
    Hoy WE; Wang Z; Baker PR; Kelly AM
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S178-85. PubMed ID: 12819325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors and survival of hemodialysis patients.
    Efrati S; Zaidenstein R; Dishy V; Beberashvili I; Sharist M; Averbukh Z; Golik A; Weissgarten J
    Am J Kidney Dis; 2002 Nov; 40(5):1023-9. PubMed ID: 12407648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers for cardiovascular and renal morbidity: expectations for an intervention programme in an Australian aboriginal community.
    Hoy WE; McFarlane R; Pugsley DJ; Norman R; Mathews JD
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S33-7. PubMed ID: 8886511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemic of renal failure among Australian Aboriginals.
    Spencer JL; Silva DT; Snelling P; Hoy WE
    Med J Aust; 1998 Jun; 168(11):537-41. PubMed ID: 9640302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney disease in Australian aboriginals: time for decisive action.
    Thomas MA
    Med J Aust; 1998 Jun; 168(11):532-3. PubMed ID: 9640299
    [No Abstract]   [Full Text] [Related]  

  • 13. The DD genotype of the angiotensin-converting enzyme gene occurs in very low frequency in Australian Aboriginals.
    Lester S; Heatley S; Bardy P; Bahnisch J; Bannister K; Faull R; Clarkson A
    Nephrol Dial Transplant; 1999 Apr; 14(4):887-90. PubMed ID: 10328464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and renal failure in diabetes.
    Hiremath S; Zimmerman D; Knoll GA
    Kidney Int; 2006 Oct; 70(7):1377; author reply 1378. PubMed ID: 16988744
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.
    Kolesnyk I; Struijk DG; Dekker FW; Krediet RT
    Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease in the Northern Territory: current and future treatment costs.
    You J; Hoy W; Zhao Y; Beaver C; Eagar K
    Med J Aust; 2002 May; 176(10):461-5. PubMed ID: 12065008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.
    Giatras I; Lau J; Levey AS
    Ann Intern Med; 1997 Sep; 127(5):337-45. PubMed ID: 9273824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal disease, the metabolic syndrome, and cardiovascular disease.
    Hoy WE; Kondalsamy-Chennakesavan S; McDonald S; Wang Z
    Ethn Dis; 2006; 16(2 Suppl 2):S2-46-51. PubMed ID: 16774010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.
    So WY; Ozaki R; Chan NN; Tong PC; Ho CS; Lam CW; Ko GT; Chow CC; Chan WB; Ma RC; Chan JC
    Hypertension; 2004 Sep; 44(3):294-9. PubMed ID: 15249544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.